Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?

被引：12
|
作者：
Maan, Raoel [1 ]
Feld, Jordan J. [2 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Toronto, Toronto Ctr Liver Dis, Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
来源：
GASTROENTEROLOGY | 2017年 / 153卷 / 04期
关键词：
SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; REDUCES RISK; LIVER; RECURRENCE; INFECTION; CANCER;
D O I：
10.1053/j.gastro.2017.08.052
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：890 / 892
页数：3
相关论文
共 50 条
  • [31] Interaction Between Hepatocellular Carcinoma and Hepatitis C Eradication With Direct-acting Antiviral Therapy
    Venkata Rajesh Konjeti
    Binu V. John
    Current Treatment Options in Gastroenterology, 2018, 16 (2) : 203 - 214
  • [32] Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma
    Lin, Wei-Chen
    Lin, Yang-Sheng
    Chang, Chen-Wang
    Chang, Ching-Wei
    Wang, Tsang-En
    Wang, Horng-Yuan
    Chen, Ming-Jen
    PLOS ONE, 2020, 15 (05):
  • [33] Unusually Aggressive Hepatocellular Carcinoma Developing After Treatment of Hepatitis C With Direct-Acting Antivirals
    Issa, Danny
    Dessie, Sofanit
    Matherly, Scott
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1184 - S1184
  • [34] HEPATOCELLULAR CARCINOMA INCIDENCE DECLINES AFTER WIDESPREAD INTRODUCTION OF DIRECT-ACTING ANTIVIRALS FOR HEPATITIS C
    Beste, Lauren
    Green, Pamela
    Berry, Kristin
    Belperio, Pamela S.
    Ioannou, George N.
    GASTROENTEROLOGY, 2020, 158 (06) : S179 - S180
  • [35] Risk of hepatocellular carcinoma among patients with hepatitis C virus cirrhosis treated with direct-acting antiviral therapy: An Australian experience
    Snell, J.
    Hong, T.
    Glasgow, S.
    Papaluca, T.
    New, K.
    Mcclure, T.
    Bell, S.
    Demeduik, B.
    Jeremiah, C.
    Tran, S.
    Phan, D.
    Jarman, M.
    Iser, D.
    Lust, M.
    Shaw, G.
    Desmond, P.
    Croagh, C.
    Visvanathan, K.
    Howell, J.
    Ryan, M.
    Thompson, A. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 80 - 81
  • [36] Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C
    Tagkou, Nikoletta M.
    Goossens, Nicolas
    Negro, Francesco
    HEPATOMA RESEARCH, 2022, 8
  • [37] Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis
    Frazzoni, Leonardo
    Sikandar, Usama
    Metelli, Flavio
    Sadalla, Sinan
    Mazzella, Giuseppe
    Bazzoli, Franco
    Fuccio, Lorenzo
    Azzaroli, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [38] Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
    Chi, Chen-Ta
    Chen, Chi-Yi
    Su, Chien-Wei
    Chen, Po-Yueh
    Chu, Chi-Jen
    Lan, Keng-Hsin
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (03) : 385 - 395
  • [39] Improving Liver Transplant Outcomes for Hepatitis C Virus Hepatocellular Carcinoma in the Direct-Acting Antiviral Therapy Era
    Okumura, Kenji
    Sogawa, Hiroshi
    Samson, David
    Butler, Jonathan
    Veillette, Gregory
    John, Devon
    Diflo, Thomas
    Bodin, Roxana
    Wolf, David C.
    Latifi, Rifat
    Nishida, Seigo
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (07) : 1834 - 1838
  • [40] Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report
    Kurokawa, Ken
    Ohki, Takamasa
    Kato, Jun
    Fukumura, Yukiyo
    Imai, Makoto
    Shibata, Chikako
    Arai, Junya
    Kondo, Mayuko
    Takagi, Kaoru
    Kojima, Kentaro
    Seki, Michiharu
    Mori, Masaya
    Toda, Nobuo
    Tagawa, Kazumi
    JOURNAL OF MEDICAL CASE REPORTS, 2020, 14 (01)
12345